Public Employees Retirement Association of Colorado Has $21.41 Million Stock Position in The Cooper Companies, Inc. (NASDAQ:COO)

Public Employees Retirement Association of Colorado lessened its position in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 0.2% during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 245,235 shares of the medical device company’s stock after selling 558 shares during the quarter. Public Employees Retirement Association of Colorado owned about 0.12% of Cooper Companies worth $21,409,000 at the end of the most recent quarter.

Other hedge funds have also added to or reduced their stakes in the company. Brown Advisory Inc. acquired a new position in shares of Cooper Companies in the 4th quarter valued at $243,000. PNC Financial Services Group Inc. boosted its holdings in Cooper Companies by 1.6% during the fourth quarter. PNC Financial Services Group Inc. now owns 21,385 shares of the medical device company’s stock worth $8,093,000 after buying an additional 346 shares during the last quarter. UBS Group AG increased its stake in shares of Cooper Companies by 9.7% in the 4th quarter. UBS Group AG now owns 80,587 shares of the medical device company’s stock valued at $30,497,000 after acquiring an additional 7,148 shares during the last quarter. Corient Private Wealth LLC raised its position in shares of Cooper Companies by 5.4% in the 4th quarter. Corient Private Wealth LLC now owns 5,974 shares of the medical device company’s stock valued at $2,261,000 after acquiring an additional 304 shares during the period. Finally, Franklin Resources Inc. boosted its stake in Cooper Companies by 1.2% during the 4th quarter. Franklin Resources Inc. now owns 3,401 shares of the medical device company’s stock worth $1,287,000 after acquiring an additional 41 shares during the last quarter. Institutional investors own 24.39% of the company’s stock.

Cooper Companies Stock Performance

Shares of COO opened at $110.49 on Friday. The stock has a market capitalization of $22.00 billion, a price-to-earnings ratio of 64.99, a PEG ratio of 2.60 and a beta of 0.98. The Cooper Companies, Inc. has a 12 month low of $75.93 and a 12 month high of $112.38. The firm has a fifty day simple moving average of $97.54 and a 200 day simple moving average of $95.48. The company has a current ratio of 1.99, a quick ratio of 1.18 and a debt-to-equity ratio of 0.33.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings data on Wednesday, August 28th. The medical device company reported $0.96 EPS for the quarter, topping analysts’ consensus estimates of $0.91 by $0.05. The company had revenue of $1 billion during the quarter, compared to the consensus estimate of $997.30 million. Cooper Companies had a net margin of 9.45% and a return on equity of 9.08%. The company’s quarterly revenue was up 7.8% on a year-over-year basis. During the same period in the prior year, the business posted $0.84 EPS. Research analysts forecast that The Cooper Companies, Inc. will post 3.66 EPS for the current fiscal year.

Insider Buying and Selling at Cooper Companies

In other news, CEO Albert G. White III sold 114,992 shares of the company’s stock in a transaction that occurred on Thursday, September 19th. The stock was sold at an average price of $110.53, for a total transaction of $12,710,065.76. Following the sale, the chief executive officer now owns 165,273 shares in the company, valued at approximately $18,267,624.69. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. In related news, CFO Brian G. Andrews sold 24,788 shares of the firm’s stock in a transaction dated Thursday, September 5th. The shares were sold at an average price of $105.90, for a total value of $2,625,049.20. Following the completion of the sale, the chief financial officer now directly owns 6,614 shares in the company, valued at approximately $700,422.60. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Albert G. White III sold 114,992 shares of the business’s stock in a transaction that occurred on Thursday, September 19th. The stock was sold at an average price of $110.53, for a total value of $12,710,065.76. Following the transaction, the chief executive officer now directly owns 165,273 shares in the company, valued at approximately $18,267,624.69. The disclosure for this sale can be found here. Insiders sold a total of 256,373 shares of company stock worth $27,637,427 over the last ninety days. 2.00% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

Several equities research analysts have weighed in on the stock. Morgan Stanley increased their target price on shares of Cooper Companies from $95.00 to $104.00 and gave the stock an “equal weight” rating in a report on Tuesday, September 10th. Jefferies Financial Group raised Cooper Companies from a “hold” rating to a “buy” rating and raised their price objective for the stock from $107.00 to $115.00 in a research note on Tuesday, July 16th. Needham & Company LLC restated a “hold” rating on shares of Cooper Companies in a report on Thursday, August 29th. Stifel Nicolaus reiterated a “buy” rating and set a $115.00 price objective (up previously from $110.00) on shares of Cooper Companies in a report on Thursday, August 29th. Finally, Wells Fargo & Company increased their target price on Cooper Companies from $110.00 to $115.00 and gave the stock an “overweight” rating in a research note on Thursday, August 29th. Four research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. Based on data from MarketBeat.com, Cooper Companies presently has a consensus rating of “Moderate Buy” and a consensus price target of $115.00.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.